Gerresheimer AG (GXI)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 31.34 |
|---|---|
| 52-week range | 14.83 – 33.28 |
| Return, 1 month / 3 months | +17.5% / +18.2% |
| Return, 1 year / 3 years | +12.3% / −67.7% |
| Trend | Uptrend |
| RSI (14) | 61 |
| Volatility (1 year) | 69.8% |
| Worst drawdown (1 year) | -46.6% |
| Average daily value traded | 4.00M EUR |
| Dividend yield | 0.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Gerresheimer AG makes packaging and delivery systems for medicines and healthcare products. The company produces glass vials, ampoules, syringes, cartridges and plastic containers, along with drug delivery devices such as inhalers and insulin pens. Its customers are pharmaceutical, biotech and healthcare companies that need sterile and reliable packaging for their products. Gerresheimer is based in Düsseldorf, Germany, and serves customers in Europe, the Americas and Asia through manufacturing sites in several countries.
On this site Gerresheimer AG appears as a stock on the XETRA Stock Exchange (Germany), code GXI, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Gerresheimer AG (GXI) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 31.34 on 23 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 250 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 12.3% and over the last three months it rose 18.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 89 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 24.9% | ||
| From 52-week high | -4.3% | ||
| Momentum | 75 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 18.2% | ||
| 6-month return | 39.5% | ||
| 12-month return, skipping the last month | -4.4% | ||
| Stability (higher is calmer) | 16 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 69.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -46.6% | ||
| Liquidity | 84 · Strong | Trades actively. | |
| Average daily value traded | 4.00M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 25 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.1% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +3.0% |
|---|---|
| 1 month | +17.5% |
| 3 months | +18.2% |
| 6 months | +39.5% |
| 1 year | +12.3% |
| 3 years | −67.7% |
| 5 years | −57.9% |
Signals
| 50-day / 200-day average | 28.26 / 25.09 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.16 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 Jun 2026 | EUR 0.0400 |
| 6 Jun 2025 | EUR 0.0400 |
| 6 Jun 2024 | EUR 1.2500 |
| 8 Jun 2023 | EUR 1.2500 |
| 9 Jun 2022 | EUR 1.2500 |
| 10 Jun 2021 | EUR 1.2500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.